Literature DB >> 993350

Flaujeac factor deficiency. Reconstitution with highly purified bovine high molecular weight-kininogen and delineation of a new permeability-enhancing peptide released by plasma kallikrein from bovine high molecular weight-kininogen.

R T Matheson, D R Miller, M J Lacombe, Y N Han, S Iwanaga, H Kato, K D wuepper.   

Abstract

Flaujeac trait is the functional deficiency of a plasma protein of the intrinsic coagulation, kinin-forming, and plasma fibrinolytic pathways. The Flaujeac factor in man has been isolated and tentatively identified as a kininogen of high molecular weight (HMW). Highly purified bovine HMW-kininogen, but not bovine low molecular weight kininogen, repaired Flaujeac factor deficiency. The two subspecies of this molecule, HMW-kininogen a and HMW-kininogen b, also corrected Flaujeac factor deficiency. When bovine HMW-kininogen was incubated with bovine plasma kallikrein, kinin-free HMW-kininogen, bradykinin, and a glycopeptide fragment (peptide 1-2; 12,584 daltons) were rapidly released. None of these fragmentation products corrected Flaujeac factor deficiency alone or in mixtures. The function of HMW-kininogen appeared to depend upon the structural integrity of the native molecule. When injected in concentrations of 2 pmol-8 nmol/0.1 ml, peptide 1-2 caused increased vascular permeability in rabbits, rats, or guinea pigs. The enhanced permeability was maximal within 1-2 min and terminated in 5-10 min, differing from that of bradykinin or histamine. Injected together in equimolar amounts, peptide 1-2 and bradykinin produced a synergistic permeability response which was immediate in onset as well as prolonged in duration. Peptide 1-2 is a rapidly acting, highly basic glyco-peptide which mediates increased vascular permeability in a complementary and synergistic manner with bradykinin.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 993350      PMCID: PMC333311          DOI: 10.1172/JCI108595

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Studies on the primary structure of bovine high-molecular-weight kininogen. Amino acid sequence of a fragment ("histidine-rich peptide") released by plasma kallikrein.

Authors:  Y N Han; M Komiya; S Iwanaga; T Suzuki
Journal:  J Biochem       Date:  1975-01-01       Impact factor: 3.387

2.  Primary structure of bovine high molecular weight kininogen: chemical compositions of kinin-free kininogen and peptide fragments released by plasma kallikrein.

Authors:  Y N Han; M Komiya; H Kato; S Iwanaga; T Suzuki
Journal:  FEBS Lett       Date:  1975-10-01       Impact factor: 4.124

3.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

4.  Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. I. An activable permeability factor and its inhibitor in guinea-pig serum.

Authors:  A A MILES; D L WILHELM
Journal:  Br J Exp Pathol       Date:  1955-02

5.  Bovine plasma high molecular weight kininogen: the amino acid sequence of fragment 1 (glycopeptide) released by the action of plasma kallikrein and its location in the precursor protein.

Authors:  Y N Han; H Kato; S Iwanaga; T Suzuki
Journal:  FEBS Lett       Date:  1976-03-15       Impact factor: 4.124

6.  Fitzgerald Trait: Deficiency of a Hitherto Unrecognized Agent, Fitzgerald Factor, Participating in Surface-Mediated Reactions of Clotting, Fibrinolysis, Generation of Kinins, and the Property of Diluted Plasma Enhancing Vascular Permeability (PF/Dil).

Authors:  H Saito; O D Ratnoff; R Waldmann; J P Abraham
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

7.  Flaujeac trait. Deficiency of human plasma kininogen.

Authors:  K D Wuepper; D R Miller; M J Lacombe
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

8.  Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways.

Authors:  R W Colman; A Bagdasarian; R C Talamo; C F Scott; M Seavey; J A Guimaraes; J V Pierce; A P Kaplan
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

9.  Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis.

Authors:  V H Donaldson; H I Glueck; M A Miller; H Z Movat; F Habal
Journal:  J Lab Clin Med       Date:  1976-02

10.  A hitherto undescribed plasma factor acting at the contact phase of blood coagulation (Flaujeac factor): case report and coagulation studies.

Authors:  M J Lacombe; B Varet; J P Levy
Journal:  Blood       Date:  1975-11       Impact factor: 22.113

View more
  9 in total

1.  Turnover of human and monkey plasma kininogens in rhesus monkeys.

Authors:  T Yamada; D A Wing; J V Pierce; G W Pettit
Journal:  J Clin Invest       Date:  1979-01       Impact factor: 14.808

2.  Purification of high molecular weight kininogen and the role of this agent in blood coagulation.

Authors:  H Saito
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

3.  Surface activation of factor XII (Hageman factor)--critical role of high molecular weight kininogen and another potentiator).

Authors:  J Y Chan; C E Burrowes; H Z Movat
Journal:  Agents Actions       Date:  1978-01

4.  Kinetic analysis of the interaction of human tissue kallikrein with single-chain human high and low molecular weight kininogens.

Authors:  M Maier; K F Austen; J Spragg
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

Review 5.  Human plasma kallikrein-kinin system: physiological and biochemical parameters.

Authors:  J W Bryant; Z Shariat-Madar
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2009-07

6.  Plasma kallikrein activation and inhibition during typhoid fever.

Authors:  R W Colman; R Edelman; C F Scott; R H Gilman
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

Review 7.  Blood Clotting and the Pathogenesis of Types I and II Hereditary Angioedema.

Authors:  Steven de Maat; Kusumam Joseph; Coen Maas; Allen P Kaplan
Journal:  Clin Rev Allergy Immunol       Date:  2021-05-06       Impact factor: 8.667

8.  Characterization of human high molecular weight kininogen. Procoagulant activity associated with the light chain of kinin-free high molecular weight kininogen.

Authors:  R E Thompson; R Mandle; A P Kaplan
Journal:  J Exp Med       Date:  1978-02-01       Impact factor: 14.307

9.  Relation between structure and correcting activity of bovine high molecular weight kininogen upon the clotting time of Fitzgerald-trait plasma.

Authors:  A G Scicli; R Waldmann; J A Guimaraes; G Scicli; O A Carretero; H Kato; Y N Han; S Iwanaga
Journal:  J Exp Med       Date:  1979-04-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.